½ÃÀ庸°í¼­
»óǰÄÚµå
1269706

¼¼°èÀÇ °æ¼º ³»½Ã°æ ½ÃÀå ±Ô¸ð Á¶»ç ¹× ¿¹Ãø : Á¦Ç°º°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº° ºÐ¼®(2022-2029³â)

Global Rigid Endoscopes Market Size study & Forecast, by Product by End Use, and Regional Analysis, 2022-2029

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è °æ¼º ³»½Ã°æ ½ÃÀåÀº 2021³â¿¡ ¾à 56¾ï ´Þ·¯·Î Æò°¡µÇ°í, ¿¹Ãø±â°£ 2022-2029³â¿¡´Â 7.10% ÀÌ»óÀÇ °ÇÀüÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

°æ¼º ³»½Ã°æÀº ¿Ü°æÀÌ 1-12mm·Î ±¤¹üÀ§¿¡ °ÉÃÄ ÀÖÀ¸¸ç, ·»Áî¿Í ±¤·Î¸¦ ¼ö³³ÇÏ´Â ±Ý¼ÓÁ¦ Æ©ºê·Î ¸¸µé¾îÁ® ÀÖ½À´Ï´Ù. ÀϹÝÀûÀ¸·Î °æ¼º ³»½Ã°æ¿¡´Â °íÇØ»óµµ ±¤ÇÐ À¯¸®ºÀ ·»Áî°¡ ÀåÂøµÇ¾î ÀÖ½À´Ï´Ù. °æ¼º ³»½Ã°æ ½ÃÀåÀº ÃÖ¼Òħ½À ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ°í ¼¼°èÀÇ ¸¸¼º Áúȯ ¸¸¿¬°ú °°Àº ¿äÀÎÀ¸·Î È®´ëµÇ°í ÀÖ½À´Ï´Ù.

Àü¼¼°è ÀϺΠ»ç¶÷µéÀº Àڱà ³»¸·Áõ°ú °£¾Ï°ú °°Àº ¸¸¼º Áúȯ°ú ½Î¿ì°í ÀÖ½À´Ï´Ù. 2021³â WHO ÆÑÆ® ½ÃÆ®¿¡ µû¸£¸é Àڱ󻸷ÁõÀº »ý½Ä ¿¬·É¿¡ ÀÖ´Â Àü¼¼°è 1¾ï 9,000¸¸ ¸í ÀÌ»óÀÇ ¿©¼º¿¡°Ô ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ÀÌ¿Í À¯»çÇϰÔ, ¿©¼º »ý½Ä±â°è¿¡¼­ °ËÃâµÇ´Â °¡Àå ÀüÇüÀûÀÎ Á¾¾ç Áß Çϳª´Â ÀڱñÙÁ¾(UF)À¸·Î, Àڱà ÆòȰ±ÙÁ¾(UL), ¼¶À¯Á¾, ÆòȰ±ÙÁ¾À̶ó°íµµ ºÒ¸°´Ù. ¿¹¸¦ µé¾î, 2022³â ÃֽŠÁ¶»ç¿¡ µû¸£¸é UFÀÇ °¡´É¼ºÀº 20%¿¡¼­ 77%·Î ¿¹ÃøµÇ¸ç, 35¼¼ ÀÌÇÏ ¿©¼º¿¡¼­´Â 40%¿¡¼­ 60%, 50¼¼ ÀÌ»ó ¿©¼º¿¡¼­´Â 70%¿¡¼­ 80%·Î ÃßÁ¤ µË´Ï´Ù. ÀÌ·¯ÇÑ Áúº´ÀÇ Áõ°¡´Â ¹Ì·¡¿¡ º¹°­°æ Ä¡·á¸¦ °­È­ÇÏ°í °æ¼º ³»½Ã°æÀÇ ¼ö¿ä¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ ÇコÄɾî ÁöÃâÀÇ Áõ°¡, ¼ÒÈ­±â°è ¹× ºÎÀΰú°è ÁúȯÀÇ À¯º´·üÀÇ »ó½Â, FDA ½ÂÀÎÀÇ Áõ°¡°¡ ½ÃÀå ¼ºÀåÀ» À§ÇÑ ÄÉÀÌÅ͸µÀÌ µÇ°í ÀÖ½À´Ï´Ù. ±×·¯³ª °æ¼º ³»½Ã°æÀº ºñ¿ëÀÌ ³ô±â ¶§¹®¿¡ ½ÃÀå ¼ºÀåÀ» ¹æÇØ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

°æ¼º ³»½Ã°æ ¼¼°è ½ÃÀå Á¶»ç¿¡¼­ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, Áß³²¹Ì ¹× ±âŸ À¯·´À» Æ÷ÇÔÇÕ´Ï´Ù. ºÏ¹Ì´Â ºê·£µå Á¦Ç°ÀÇ ¿ìÀ§¿Í ÀÌ Áö¿ªÀÇ Áúº´ À¯º´·ü Áõ°¡·Î ¸ÅÃâ¿¡¼­ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. ¹Ý¸é ¾Æ½Ã¾ÆÅÂÆò¾çÀº ³ë³â Àα¸¿Í ´ë»ó Àα¸ Áõ°¡, Á¦Ç° °³¹ßÀ» À§ÇÑ °øµ¿ ¿¬±¸ Áõ°¡, ÁÖ¿ä ±â¾÷ÀÇ Áö¸®Àû È®´ë µîÀÇ ¿äÀÎÀ¸·Î ¿¹Ãø±â°£ µ¿¾È °¡Àå ³ôÀº CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ ¿¬±¸ÀÇ ¸ñÀûÀº ÃÖ±Ù ¸î ³â µ¿¾È ´Ù¾çÇÑ ºÎ¹®°ú ±¹°¡ÀÇ ½ÃÀå ±Ô¸ð¸¦ ÆÄ¾ÇÇϰí ÇâÈÄ ¸î ³â°£ÀÇ °¡Ä¡¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼­´Â Á¶»ç ´ë»ó ±¹°¡¿¡¼­ ¾÷°èÀÇ ÁúÀû ¹× ¾çÀû Ãø¸éÀ» Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.

¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú °úÁ¦ µî Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÁÖ¿ä ±â¾÷ÀÇ °æÀï »óȲ°ú Á¦Ç° Á¦°ø¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚ°¡ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¹Ì½ÃÀû ½ÃÀå¿¡¼­ÀÇ ÀáÀçÀûÀÎ ±âȸµµ Æ÷ÇÔÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå ÇöȲ
  • ¼¼°è¡¤ºÎ¹®º° ½ÃÀå ÃßÁ¤¡¤¿¹Ãø, 2019-2029³â
    • °æ¼º ³»½Ã°æ ½ÃÀå, Áö¿ªº°, 2019-2029³â
    • °æ¼º ³»½Ã°æ ½ÃÀå, Á¦Ç°º°, 2019-2029³â
    • °æ¼º ³»½Ã°æ ½ÃÀå, ÃÖÁ¾ ¿ëµµº°, 2019-2029³â
  • ÁÖ¿ä µ¿Çâ
  • Á¶»ç ¹æ¹ý
  • Á¶»çÀÇ °¡Á¤

Á¦2Àå °æ¼º ³»½Ã°æ ¼¼°è ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§

  • Á¶»ç ¸ñÀû
  • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
    • Á¶»ç ´ë»ó ¹üÀ§
    • »ê¾÷ÀÇ ÁøÈ­
  • º» Á¶»çÀÇ ´ë»óÀÌ µÈ ÇØ
  • ȯÀ² º¯È¯À²

Á¦3Àå ¼¼°èÀÇ °æ¼º ³»½Ã°æ ½ÃÀå ¿ªÇÐ

  • °æ¼º ³»½Ã°æ ½ÃÀåÀÇ ¿µÇ⠺м®(2019-2029³â)
    • ½ÃÀå ÃËÁø¿äÀÎ
      • ÃÖ¼Òħ½À ¼ö¼úÀÇ ¼ö¿ä È®´ë
      • ¸¸¼º ÁúȯÀÇ Áõ°¡
    • ½ÃÀåÀÇ °úÁ¦
      • °æ¼º ³»½Ã°æÀÇ °íºñ¿ëÈ­
    • ½ÃÀå ±âȸ
      • Áõ°¡ÇÏ´Â ÇコÄɾî ÁöÃâ
      • ¼ÒÈ­±â°è, ºÎÀΰú°èÀÇ Áõ·Ê°¡ Áõ°¡

Á¦4Àå ¼¼°èÀÇ °æ¼º ³»½Ã°æ ½ÃÀå »ê¾÷ ºÐ¼®

  • Porter's 5 Force ¸ðµ¨
    • °ø±Þ±â¾÷ÀÇ Çù»ó·Â
    • ±¸¸ÅÀÚÀÇ Çù»ó·Â
    • ½Å±Ô Âü°¡¾÷üÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷ °£ÀÇ Àû´ë °ü°è
  • Porter's 5 Force ¸ðµ¨¿¡ ´ëÇÑ ¹Ì·¡Àû Á¢±Ù(2019-2029³â)
  • PEST ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦Àû
    • »çȸÀû
    • ±â¼úÀû
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«
  • ¾÷°è °ü°èÀÚ Àü¸Á
  • ¾Ö³Î¸®½ºÆ®ÀÇ ±Ç°í¿Í °á·Ð

Á¦5Àå À§Çè Æò°¡: COVID-19ÀÇ ¿µÇâ

  • COVID-19°¡ ¾÷°è¿¡ ¹ÌÄ¡´Â ÀüüÀûÀÎ ¿µÇâ¿¡ ´ëÇÑ Æò°¡
  • COVID-19 ÀÌÀü°ú COVID-19 ÀÌÈÄÀÇ ½ÃÀå ½Ã³ª¸®¿À

Á¦6Àå °æ¼º ³»½Ã°æ ¼¼°è ½ÃÀå : Á¦Ç°º°

  • ½ÃÀå ÇöȲ
  • °æ¼º ³»½Ã°æ ¼¼°è ½ÃÀå : Á¦Ç°º°, ½ÇÀû - ÀáÀç·Â ºÐ¼®
  • °æ¼º ³»½Ã°æ ¼¼°è ½ÃÀå : Á¦Ç°º° ½ÃÀå ÃßÁ¤¡¤¿¹Ãø 2019-2029
  • °æ¼º ³»½Ã°æ ½ÃÀå, ÇÏÀ§ ºÎ¹®º° ºÐ¼®
    • º¹°­°æ
    • °üÀý°æ
    • ¿ä°ü ³»½Ã°æ
    • ¹æ±¤°æ
    • ºÎÀΰú¿ë ³»½Ã°æ
    • ½Å°æ ³»½Ã°æ
    • ±âŸ

Á¦7Àå °æ¼º ³»½Ã°æ ¼¼°è ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

  • ½ÃÀå ÇöȲ
  • °æ¼º ³»½Ã°æ ¼¼°è ½ÃÀå : ÃÖÁ¾ ¿ëµµº°, ½ÇÀû - ÀáÀç·Â ºÐ¼®
  • °æ¼º ³»½Ã°æ ¼¼°è ½ÃÀå : ÃÖÁ¾ ¿ëµµº° ÃßÁ¤¡¤¿¹Ãø 2019-2029
  • °æ¼º ³»½Ã°æ ½ÃÀå, ÇÏÀ§ ºÎ¹®º° ºÐ¼®
    • º´¿ø
    • ¿Ü·¡ Áø·á ½Ã¼³

Á¦8Àå °æ¼º ³»½Ã°æ ¼¼°è ½ÃÀå : Áö¿ªº° ºÐ¼®

  • °æ¼º ³»½Ã°æ ½ÃÀå, Áö¿ªº° ½ÃÀå ÇöȲ
  • ºÏ¹Ì
    • ¹Ì±¹
      • Á¦Ç°º° ÃßÁ¤¡¤¿¹Ãø, 2019-2029³â
      • ÃÖÁ¾ ¿ëµµº° ÃßÁ¤¡¤¿¹Ãø, 2019-2029³â
    • ij³ª´Ù
  • À¯·´ÀÇ °æ¼º ³»½Ã°æ ½ÃÀå ÇöȲ
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °æ¼º ³»½Ã°æ ½ÃÀå ÇöȲ
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ °æ¼º ³»½Ã°æ ½ÃÀå ÇöȲ
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • ¼¼°èÀÇ ±âŸ Áö¿ª

Á¦9Àå °æÀï Á¤º¸

  • ÁÖ¿ä ½ÃÀå Àü·«
  • ±â¾÷ °³¿ä
    • Olympus Corporation
      • ÁÖ¿ä Á¤º¸
      • °³¿ä
      • À繫(µ¥ÀÌÅÍÀÇ ÀÔ¼ö°¡ °¡´ÉÇÑ °æ¿ì¸¸)
      • Á¦Ç° °³¿ä
      • ÃÖ±Ù µ¿Çâ
    • Ethicon US, LLC
    • Boston Scientific Corporation
    • Karl Storz GmbH & Co. KG
    • Stryker
    • PENTAX Medical
    • Richard Wolf Gmbh
    • Medtronic
    • FUJIFILM Holdings Corp.
    • CONMED Corp.

Á¦10Àå Á¶»ç ÇÁ·Î¼¼½º

  • Á¶»ç ÇÁ·Î¼¼½º
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • ºÐ¼®
    • ½ÃÀå ÃßÁ¤
    • °ËÁõ
    • ÃâÆÇ
  • Á¶»çÀÇ Æ¯Â¡
  • Á¶»çÀÇ °¡Á¤
ksm 23.05.24

Global Rigid Endoscopes Market is valued at approximately USD 5.60 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7.10% over the forecast period 2022-2029. Rigid endoscopes have an extensive range of exterior diameters, from 1 to 12 mm, and are made of metal tubes that house the lenses and light channel. Usually, high-resolution optical glass rod lenses are found on rigid endoscopes. The Rigid Endoscopes Market is expanding because of factors such as rising demand for minimally invasive surgical procedure and the growing prevalence of chronic diseases across the world.

Several people around the world struggle with chronic conditions such as endometriosis and liver cancer. According to WHO factsheets from 2021, endometriosis affects over 190 million women worldwide who are of reproductive age. Similar to this, one of the most typical tumours detected in the female reproductive system is uterine fibroids (UFs), also known as uterine leiomyoma (UL), fibroma, or leiomyoma. For instance, a recent study in 2022 indicates that the possibility of having UFs is projected to be between 20% and 77%; the likelihood of having this condition is estimated to be between 40% and 60% among women under the age of 35 and to be between 70% and 80% among women over the age of 50. The increased prevalence of these illnesses is anticipated to enhance laparoscopic treatments in the future and hence promote the demand for rigid endoscopes. In addition, increasing healthcare spending and rising prevalence of gastrointestinal and gynecological cases and rising FDA approvals is catering for the market growth. However, the high cost of rigid endoscopes may halt market growth.

The key regions considered for the Global Rigid Endoscopes Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded products and the region's increasing disease prevalence. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for product development, and the geographic expansion of key players.

Major market player included in this report are:

  • Olympus Corporation
  • Ethicon U.S., LLC
  • Boston Scientific Corporation
  • Karl Storz GmbH & Co. KG
  • Stryker
  • PENTAX Medical
  • Richard Wolf GmbH
  • Medtronic
  • FUJIFILM Holdings Corp.
  • CONMED Corp.

Recent Developments in the Market:

  • In January 2021, Olympus Corp. announced the acquisition of Quest Photonic Devices. These acquisitions take place to strengthen the company's presence in the surgical endoscopy market.

Global Rigid Endoscopes Market Report Scope:

  • Historical Data 2019-2020-2021
  • Base Year for Estimation 2021
  • Forecast period 2022-2029
  • Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered Product, End Use, Region
  • Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Product:

  • Laparoscopes
  • Arthroscopes
  • Ureteroscopes
  • Cystoscopes
  • Gynecology Endoscopes
  • Neuroendoscopes
  • Others

By End Use:

  • Hospitals
  • Outpatient Facilities

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Rigid Endoscopes Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Rigid Endoscopes Market, by Product, 2019-2029 (USD Billion)
    • 1.2.3. Rigid Endoscopes Market, by End use, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Rigid Endoscopes Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Rigid Endoscopes Market Dynamics

  • 3.1. Rigid Endoscopes Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Growing demand for minimally invasive surgical Procedure
      • 3.1.1.2. Growing prevelance of chronic diseases
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Rigid Endoscopes
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing healthcare spending
      • 3.1.3.2. Rising prevelance of gastrointestinal and gynaecological cases

Chapter 4. Global Rigid Endoscopes Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Rigid Endoscopes Market, by Product

  • 6.1. Market Snapshot
  • 6.2. Global Rigid Endoscopes Market by Product, Performance - Potential Analysis
  • 6.3. Global Rigid Endoscopes Market Estimates & Forecasts by Product 2019-2029 (USD Billion)
  • 6.4. Rigid Endoscopes Market, Sub Segment Analysis
    • 6.4.1. Laparoscopes
    • 6.4.2. Arthroscopes
    • 6.4.3. Ureteroscopes
    • 6.4.4. Cystoscopes
    • 6.4.5. Gynecology Endoscopes
    • 6.4.6. Neuroendoscopes
    • 6.4.7. Others

Chapter 7. Global Rigid Endoscopes Market, by End use

  • 7.1. Market Snapshot
  • 7.2. Global Rigid Endoscopes Market by End use, Performance - Potential Analysis
  • 7.3. Global Rigid Endoscopes Market Estimates & Forecasts by End use 2019-2029 (USD Billion)
  • 7.4. Rigid Endoscopes Market, Sub Segment Analysis
    • 7.4.1. Hospitals
    • 7.4.2. Outpatient Facilities

Chapter 8. Global Rigid Endoscopes Market, Regional Analysis

  • 8.1. Rigid Endoscopes Market, Regional Market Snapshot
  • 8.2. North America Rigid Endoscopes Market
    • 8.2.1. U.S. Rigid Endoscopes Market
      • 8.2.1.1. Product breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. End use breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Rigid Endoscopes Market
  • 8.3. Europe Rigid Endoscopes Market Snapshot
    • 8.3.1. U.K. Rigid Endoscopes Market
    • 8.3.2. Germany Rigid Endoscopes Market
    • 8.3.3. France Rigid Endoscopes Market
    • 8.3.4. Spain Rigid Endoscopes Market
    • 8.3.5. Italy Rigid Endoscopes Market
    • 8.3.6. Rest of Europe Rigid Endoscopes Market
  • 8.4. Asia-Pacific Rigid Endoscopes Market Snapshot
    • 8.4.1. China Rigid Endoscopes Market
    • 8.4.2. India Rigid Endoscopes Market
    • 8.4.3. Japan Rigid Endoscopes Market
    • 8.4.4. Australia Rigid Endoscopes Market
    • 8.4.5. South Korea Rigid Endoscopes Market
    • 8.4.6. Rest of Asia Pacific Rigid Endoscopes Market
  • 8.5. Latin America Rigid Endoscopes Market Snapshot
    • 8.5.1. Brazil Rigid Endoscopes Market
    • 8.5.2. Mexico Rigid Endoscopes Market
    • 8.5.3. Rest of Latin America Rigid Endoscopes Market
  • 8.6. Rest of The World Rigid Endoscopes Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Olympus Corporation
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Ethicon U.S., LLC
    • 9.2.3. Boston Scientific Corporation
    • 9.2.4. Karl Storz GmbH & Co. KG
    • 9.2.5. Stryker
    • 9.2.6. PENTAX Medical
    • 9.2.7. Richard Wolf Gmbh
    • 9.2.8. Medtronic
    • 9.2.9. FUJIFILM Holdings Corp.
    • 9.2.10. CONMED Corp.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦